MoonLake Immunotherapeutics
MLTX
#5863
Rank
A$1.56 B
Marketcap
A$22.10
Share price
5.01%
Change (1 day)
-69.31%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -A$0.33 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.18 Billion a decrease over its 2023 earnings that were of -A$77.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.33 Billion85.56%
2024 -A$0.18 Billion129.45%
2023 -A$77.11 Million-16.81%
2022 -A$92.7 Million